Lately, a significant association between DRD2 genetic polymorphisms and hyperprolactinemia has been established in children with ASD (Sukasem et al., 2016; Hongkaew et al., 2021a; Soria-Chacartegui et al., 2021). Here, DRD2 is linked to hyperprolactinemia.